Impact of inflow reconstruction on infrainguinal bypass

M J Eagleton1, K A Illig, R M Green

  • 1Department of Surgery, University of Rochester Medical Center, NY 14642, USA.

Insights

Multisegmental disease requiring inflow procedures in infrainguinal bypass grafting may lower primary patency rates, but limb salvage and survival remain unaffected. Patient surveillance is recommended to monitor inflow disease progression.

Area of Science:

  • Vascular Surgery
  • Graft Patency Analysis
  • Peripheral Artery Disease

Background:

  • Infrainguinal bypass grafting is crucial for limb salvage in patients with peripheral artery disease.
  • Multisegmental disease may necessitate inflow procedures, potentially impacting graft outcomes.
  • Understanding the effect of inflow source on bypass success is vital for surgical decision-making.

Purpose of the Study:

  • To evaluate if severe multisegmental disease requiring inflow procedures affects infrainguinal bypass graft patency, limb salvage, and patient survival.
  • To compare outcomes between grafts with reconstructed vs. normal inflow sources.

Main Methods:

  • Retrospective review of 551 infrainguinal bypass grafts in 495 patients.
  • Separate analysis of saphenous vein and prosthetic grafts.
  • Comparison of graft patency, limb salvage, and survival rates based on inflow source (reconstructed vs. normal).
  • Identification of graft failure causes.

Main Results:

  • Vein grafts from reconstructed inflow had lower 4-year primary patency (41% vs 54%; p=0.006), but similar assisted and secondary patency.
  • Prosthetic graft patency rates were not significantly different based on inflow source.
  • Inflow failure was a common cause of occlusion, particularly in grafts with multisegmental disease (24% vein, 22% prosthetic).
  • Inflow procedures did not impact limb salvage or survival rates.

Conclusions:

  • Reconstructed inflow sources do not adversely affect long-term infrainguinal bypass outcomes, limb salvage, or survival.
  • Inflow failure is a significant cause of occlusion in patients with multisegmental disease.
  • Enhanced patient surveillance for inflow disease progression is recommended for these high-risk patients to enable timely intervention and prevent graft occlusion.
Abstract